CJC-1295 with vs without DAC is the choice that confuses most first-time CJC users because both versions are sold as “CJC-1295” but produce dramatically different effects. CJC-1295 with DAC has a 7-day half-life and is dosed once or twice weekly; CJC-1295 no DAC (Mod GRF 1-29) has a 30-minute half-life and is dosed daily. The choice affects everything: whether you stack with Ipamorelin daily, whether GH release is pulsatile or sustained, and how fast receptor desensitization develops. This guide explains the molecular difference, when to choose each version, and why “no DAC” has become the standard recommendation for most users.
The DAC versus no-DAC question is the most-confused topic in peptide forums. Both versions work, but they work differently and the choice has real implications for your protocol design.
What Is the DAC?
DAC stands for Drug Affinity Complex. It is a chemical modification (a maleimidopropionic acid linker) added to the CJC-1295 peptide that allows it to covalently bind to serum albumin in the bloodstream.
The result: the peptide effectively becomes albumin-bound, dramatically extending its half-life from 30 minutes to about 7 days. The albumin binding protects the peptide from rapid clearance and produces sustained low-level GH-releasing activity throughout the week.
“No DAC” CJC-1295 is the same 30-amino-acid peptide without this albumin-binding modification. It is sometimes called Mod GRF 1-29 or simply “CJC-1295 no DAC”.
CJC-1295 With DAC vs Without DAC: Side by Side
| Property | CJC-1295 with DAC | CJC-1295 no DAC (Mod GRF 1-29) |
|---|---|---|
| Half-life | ~7 days | ~30 minutes |
| Frequency | 1 to 2x per week | Daily, often pre-bed |
| GH release pattern | Sustained, low-amplitude | Pulsatile, high-amplitude |
| Stacks with Ipamorelin | Less effective (constant elevation blunts pulse) | Excellent (synchronized pulse) |
| Receptor desensitization | Faster | Slower |
| Cycle length recommended | 8 to 12 weeks | 12 to 16 weeks |
| Best for | Convenience, set-and-forget | Body recomposition, mimicking natural GH rhythm |
| Cost per cycle | Lower (less peptide used) | Higher (daily injections) |
Why No-DAC Is the Modern Standard
Three main reasons most experienced users prefer no-DAC:
- Mimics natural GH rhythm: GH is released in pulses, not continuously. The body’s own GH pulses peak during deep sleep. No-DAC CJC-1295 dosed pre-bed produces a single strong pulse synchronized with this natural peak. DAC version produces constant low-level elevation that does not match the natural pattern.
- Better stacking with Ipamorelin: the gold-standard GH protocol pairs CJC-1295 with Ipamorelin for additive pulse magnitude. This synergy works best with synchronized daily dosing of both peptides. DAC’s continuous elevation blunts the discrete Ipamorelin pulse.
- Slower receptor desensitization: pulsatile activation lets pituitary GH receptors recover between pulses. Continuous activation (DAC) keeps receptors busy and accelerates downregulation.
When DAC Version Is Worth Using
Specific scenarios where DAC makes sense:
- Convenience-driven users: 1 to 2 injections per week vs daily. For users who genuinely struggle with daily injection adherence, DAC ensures the peptide gets into the body even if motivation flags.
- Travel-heavy users: less peptide management on the road. Inject before a trip, receive sustained effect for the week.
- Sustained baseline elevation goals: if your goal is general age-related GH support rather than recomposition, the constant elevation is acceptable.
- Standalone use without GHRP stacking: if you are not adding Ipamorelin, the synchronized pulse advantage of no-DAC is less relevant.
Dosing Protocols
CJC-1295 with DAC
- Dose: 1 to 2 mg subcutaneous
- Frequency: once or twice per week
- Timing: any time of day; consistent day-of-week is preferred
- Cycle: 8 to 12 weeks on, 4 weeks off
CJC-1295 no DAC (Mod GRF 1-29)
- Dose: 100 mcg subcutaneous
- Frequency: daily, pre-bed (or fasted morning)
- Timing: 30 to 60 minutes before sleep, on empty stomach
- Cycle: 12 to 16 weeks on, 4 weeks off
For body composition goals, pair no-DAC CJC-1295 with 250 mcg Ipamorelin daily. See our CJC + Ipamorelin guide for the full protocol.
Reconstitution
CJC-1295 with DAC (5 mg vial)
- Add 2.5 mL bacteriostatic water → 2 mg/mL
- 2 mg dose = 1 mL (100 units)
- 1 mg dose = 0.5 mL (50 units)
CJC-1295 no DAC (5 mg vial)
- Add 2.5 mL bacteriostatic water → 2 mg/mL
- 100 mcg dose = 0.05 mL (5 units)
Side Effects
DAC version
- Mild flushing at injection
- Slight prolonged fluid retention (longer than no-DAC because of sustained activity)
- Faster receptor desensitization
- Occasional injection site reactions
No-DAC version
- Brief mild flushing in first 5 to 10 minutes after injection
- Vivid dreams
- Slight water retention (less than DAC, usually resolves by week 3)
- Hand numbness at high doses (uncommon at standard 100 mcg)
Common CJC-1295 DAC Mistakes
- Daily DAC dosing: defeats the purpose. The DAC modification is designed for weekly dosing; daily DAC dosing accelerates receptor desensitization without proportional benefit.
- Stacking DAC with Ipamorelin: the constant elevation from DAC blunts the discrete Ipamorelin pulse. Use no-DAC for stacking.
- Confusing the two products: vials labeled simply “CJC-1295” should specify which version. Always confirm before reconstitution because dosing differs by 10x.
- Expecting recomp from DAC: DAC produces general health effects but is suboptimal for body composition compared to no-DAC pulse pattern.
Frequently Asked Questions
Which version should a first-time user choose?
No-DAC, paired with Ipamorelin daily pre-bed. This is the protocol with the most positive customer outcomes and the cleanest side effect profile. DAC version is for users who specifically need the convenience.
Can I switch from DAC to no-DAC mid-protocol?
Yes. Stop DAC, wait 2 weeks for albumin-bound peptide to clear, then start no-DAC daily. The two are not interchangeable on a 1:1 basis; recalibrate dose.
Is DAC version safer than no-DAC?
Neither is meaningfully safer. Both have similar side effect profiles at appropriate doses. The choice is about effect pattern (pulsatile vs sustained) rather than safety.
Why does DAC desensitize receptors faster?
Continuous activation of any receptor leads to downregulation. Pulsatile activation lets receptors recover between pulses. The DAC modification keeps GHRH receptors active 24/7, accelerating the desensitization process.
Where can I get CJC-1295 (DAC and no-DAC)?
For research-grade CJC-1295 in both DAC and no-DAC forms in Indonesia and Southeast Asia, see our pricelist. We label vials clearly and confirm version before shipping. Order directly via WhatsApp.
This article is for informational and research-use purposes only. CJC-1295 is not approved by the FDA for human therapeutic use. Always consult a qualified medical professional before starting any new protocol.